| 122.00 |  +1.66 / +1.38% |
Data as of 4:01pm ET | Day’s Change |
| 122.00 |  0.00 / 0.00% |
Volume: 7.3K |
| Which Generic Drugmaker Is Your Best Buy Today? 4:21pm / MotleyFool.com | AZN Updates on Pulmicort Respules - Analyst Blog May 28 / Zacks.com |
| CRL for Endo Health's Aveed - Analyst Blog Jun 03 / Zacks.com | Pharma M&A: defensive deals May 28 / FT.com |
| Shire Settles Lawsuit with Teva - Analyst Blog Jun 03 / Zacks.com | 1 Reason to Expect Big Things from Actavis May 28 / MotleyFool.com |
| Two Top Endo Executives Depart - Analyst Blog May 30 / Zacks.com | Bausch & Lomb - successful outcome May 27 / FT.com |
| Has Actavis Made You Any Fast Money? May 29 / MotleyFool.com | Valeant pays $8.7 billion for Bausch & Lomb May 27 / CNNMoney.com |
| Previous close | 120.34 |
| Today’s open | 119.98 |
| Day’s range | 119.13 - 122.12 |
| Volume | 1,197,913 |
| Average volume (3 months) | 1,647,471 |
| Market cap | $16.0B |
| Dividend yield | -- |
| Earnings growth (last year) | -63.11% |
| Earnings growth (this year) | +38.25% |
| Earnings growth (next 5 years) | +12.00% |
| Revenue growth (last year) | +29.02% |
| P/E ratio | NM |
| Price/Sales | 1.83 |
| Price/Book | 4.01 |
| Today’s change | Today’s % change | |
|---|---|---|
| ZTSZoetis Inc | -0.09 | -0.28% |
| VRTXVertex Pharmaceutica... | +1.07 | +1.39% |
| ALXNAlexion Pharmaceutic... | +2.07 | +2.28% |
| SHPGShire PLC | +0.19 | +0.19% |
| Next reporting date | July 31, 2013 |
| EPS forecast (this quarter) | $2.00 |
| Annual revenue (last year) | $5.9B |
| Annual profit (last year) | $97.3M |
| Net profit margin | 1.65% |
Sector Health Technology |
Industry Pharmaceuticals: Generic |
President, Chief Executive Officer & Director Paul M. Bisaro |
Global Chief Financial Offi cer R. Todd Joyce, CPA |
Corporate headquarters Parsippany, New Jersey |
.
